Editorial: Metabolic Disturbances in Mental Illness: Neuropathogenetic Mechanisms and Therapeutic Implications by Chao Deng, Chao Deng, Jeffrey K. Yao, Jeffrey K. Yao

Get full text

Neurosteroids in Schizophrenia: Pathogenic and Therapeutic Implications by HuaLin Cai, HuaLin Cai, Ting Cao, Ting Cao, Xiang Zhou, Xiang Zhou, Jeffrey K. Yao, Jeffrey K. Yao, Jeffrey K. Yao

Get full text

Membrane Pathology in Schizophrenia: Implication for Arachidonic Acid Signaling by Jeffrey K. Yao, Ravinder K. Reddy

Get full text

Reduced Levels and Disrupted Biosynthesis Pathways of Plasma Free Fatty Acids in First-Episode Antipsychotic-Naïve Schizophrenia Patients by Xiang Zhou, Xiang Zhou, Tao Long, Tao Long, Gretchen L. Haas, Gretchen L. Haas, HuaLin Cai, HuaLin Cai, Jeffrey K. Yao, Jeffrey K. Yao, Jeffrey K. Yao

Get full text

Homeostatic imbalance of purine catabolism in first-episode neuroleptic-naïve patients with schizophrenia. by Jeffrey K Yao, George G Dougherty, Ravinder D Reddy, Matcheri S Keshavan, Debra M Montrose, Wayne R Matson, Joseph McEvoy, Rima Kaddurah-Daouk

Get full text

Lipidomics reveals early metabolic changes in subjects with schizophrenia: effects of atypical antipsychotics. by Joseph McEvoy, Rebecca A Baillie, Hongjie Zhu, Peter Buckley, Matcheri S Keshavan, Henry A Nasrallah, George G Dougherty, Jeffrey K Yao, Rima Kaddurah-Daouk

Get full text

Associations between purine metabolites and clinical symptoms in schizophrenia. by Jeffrey K Yao, Ruth Condray, George G Dougherty, Matcheri S Keshavan, Debra M Montrose, Wayne R Matson, Joseph McEvoy, Rima Kaddurah-Daouk, Ravinder D Reddy

Get full text